Researchers explore the potential of nanocarriers in enhancing the efficacy of Traditional Chinese Medicines (TCMs)
Traditional Chinese Medicines (TCMs) have long been used to treat various ailments, but their effectiveness has been hindered by issues such as poor solubility and limited bioavailability. In a recent review published in the Journal of Nanobiotechnology, researchers delve into the role of nanotechnology in improving the delivery of active components of TCMs. By utilizing nanocarriers, such as liposomes, polymeric and inorganic nanoparticles, and organic/inorganic nanohybrids, scientists aim to overcome the challenges associated with TCM delivery and achieve better therapeutic results with fewer adverse effects.
Enhancing TCM Bioavailability with Nanoparticles
Nanocarriers have emerged as a promising technique for improving the bioavailability and targeted action of TCMs. These carriers enhance the solubility and stability of TCMs, leading to increased absorption and bioavailability. Lipid nanoparticles, such as liposomes, solid lipid nanoparticles (SLNs), and nanostructured lipid carriers (NLCs), offer advantages such as biocompatibility, minimal toxicity, and controlled drug release. Additionally, microemulsions (MEs) and nanoemulsions (NEs) provide flexible drug delivery platforms with increased specific surface area. Polymer hydrogel-based systems have also shown promise in targeted and sustained TCM delivery.
Harnessing the Potential of Inorganic Nanocarriers
Inorganic nanocarriers, including gold nanoparticles (Au NPs) and mesoporous silica nanoparticles (MSNs), offer customizable size, large surface area, and surface charge, making them suitable for drug delivery. Organic and inorganic nanohybrids combine the benefits of both materials, providing stability, safety, and intelligent drug release in response to environmental cues. Prodrug-based nanocarriers have shown advantages in anticancer drug delivery, including increased drug availability and controlled release. Self-assembled nanomedicines have also demonstrated efficacy in cancer therapy.
Overcoming Challenges and Future Directions
While nanocarriers hold promise for TCM delivery, there are still challenges to overcome. Coupling different nanocarrier platforms could enhance their performance, and further research is needed to understand their assembly methods and in vivo fate. Polymeric vesicles and inorganic nanocarriers face challenges in biocompatibility and stability, requiring optimization of surface chemistry and functionalization techniques. Novel nano-level heterogotes and organic/inorganic hybrid delivery methods show potential for expanding biological applications, particularly in cancer therapy. However, stability and safety concerns must be addressed.
Conclusion: Nanocarrier-based delivery methods have shown promise in improving the therapeutic efficacy of TCMs. By enhancing bioavailability, reducing toxicity, and increasing effectiveness, nanotechnology offers a new frontier in TCM delivery. However, further research, innovation in delivery methods, and supporting technologies are needed to fully realize the potential of TCM-based nanomedicines. With continued advancements, nanotechnology could revolutionize the field of traditional medicine and pave the way for more effective and targeted treatments.
Leave a Reply